ArticleOncotarget2018

Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage 3.

Yu-Hsuan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.